Gene therapy competitive dynamics: Winner takes all
With many gene therapies in development for an increasing number of indications, their curative promise presents a unique competitive dynamic as they enter the...
Industries
Life Sciences Antitrust & Competition
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
Engagements
- 01CRA experts testify in civil antitrust trial involving alleged tying of PICC lines and location devicesOn October 3, 2022, CRA experts testified on behalf of C.R. Bard in AngioDynamics, Inc. v. C.R. Bard, Inc. et al. in the Northern District of New York....View engagement
- 02CRA experts advise on oncology, consumer health, and animal health transactions before FTCCRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint...View engagement
- 03At risk generic entry and impact of formulary statusIn a Hatch-Waxman litigation, a first-to-file generic manufacturer asked CRA to assess changes in formulary status that would result from the at-risk entry and...View engagement